Based on 2 analysts offering 12 month price targets for Silence Therapeutics PLC
Min Forecast
$32.00+135.64%
Avg Forecast
$53.50+293.96%
Max Forecast
$75.00+452.28%
Should I buy or sell SLN stock?
Based on 2 analysts offering ratings for Silence Therapeutics PLC.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SLN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SLN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their SLN stock forecasts and price targets.
Is Silence Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: SLN) stock is to Strong Buy SLN stock.
Out of 2 analysts, 1 (50%) are recommending SLN as a Strong Buy, 1 (50%) are recommending SLN as a Buy, 0 (0%) are recommending SLN as a Hold, 0 (0%) are recommending SLN as a Sell, and 0 (0%) are recommending SLN as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year SLN price target, the average SLN price target is $53.50, with the highest SLN stock price forecast at $75.00 and the lowest SLN stock price forecast at $32.00.
On average, Wall Street analysts predict that Silence Therapeutics's share price could reach $53.50 by Aug 11, 2027. The average Silence Therapeutics stock price prediction forecasts a potential upside of 293.96% from the current SLN share price of $13.58.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.